Compare CNTB & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTB | MPA |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.1M | 144.4M |
| IPO Year | 2021 | N/A |
| Metric | CNTB | MPA |
|---|---|---|
| Price | $2.25 | $11.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 502.0K | 25.2K |
| Earning Date | 03-31-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.83% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $762,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $38,289.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $9.87 |
| 52 Week High | $3.28 | $12.21 |
| Indicator | CNTB | MPA |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 41.06 |
| Support Level | $2.27 | $11.16 |
| Resistance Level | $2.56 | $11.46 |
| Average True Range (ATR) | 0.19 | 0.10 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 26.19 | 9.68 |
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with an investment objective to provide shareholders with as high a level of current income exempt from U.S. federal and Pennsylvania income taxes as is consistent with its investment policies and prudent investment management. The Fund seeks to achieve its investment objective by investing, as a fundamental policy, at least 80% of an aggregate of the Fund's net assets and the proceeds of any borrowings for investment purposes, in a portfolio of municipal obligations issued by or on behalf of the State of Pennsylvania, its political subdivisions, agencies, and instrumentalities and by other qualifying issuers.